Video Experimental Relacionado
Updated: Sep 9, 2025
09:58
Using Eggs from Schistosoma mansoni as an In vivo Model of Helminth-induced Lung Inflammation
Published on: June 5, 2012
13.9K
Desafíos terapéuticos de la esquistosomiasis: mecanismos de acción y limitaciones actuales
Abdelaali Balahbib1, Nasreddine El Omari2, Hajar Lghazi1
1High Institute of Nursing Professions and Health Techniques of Errachidia, Errachidia, Morocco.
Resumen
El tratamiento de la esquistosomiasis se enfrenta a desafíos debido a la complejidad del parásito y las limitaciones del praziquantel. Las nuevas estrategias son vitales para controlar esta enfermedad parasitaria generalizada.
Área de la Ciencia:
- Parasitología médica
- La medicina tropical
- Descubrimiento de drogas
Sus antecedentes:
- La esquistosomiasis afecta a millones de personas en todo el mundo y es causada por parásitos del género Schistosoma.
- El tratamiento actual con praziquantel se enfrenta a limitaciones que incluyen resistencia y efectos secundarios.
- La larga vida útil de los esquistosomas complica la evaluación de la eficacia del tratamiento.
Objetivo del estudio:
- Revisar los retos terapéuticos en el tratamiento de la esquistosomiasis.
- Analizar los mecanismos de acción y las limitaciones de los tratamientos existentes.
- Abogar por estrategias integradas para mejorar el control de enfermedades.
Principales métodos:
- Revisión de la literatura sobre el tratamiento de la esquistosomiasis.
- Análisis del mecanismo del praziquantel y la resistencia a los parásitos.
- Discusión de los factores biológicos que influyen en los resultados del tratamiento.
Principales resultados:
- Praziquantel induce el daño parasitario, pero enfrenta obstáculos en su eficacia.
- La biología de los esquistosomas y la modulación inmune complican el tratamiento.
- La resistencia, los efectos secundarios y la larga duración de la infección son los principales desafíos.
Conclusiones:
- El control efectivo de la esquistosomiasis requiere comprender la biología del parásito.
- Son esenciales los nuevos agentes terapéuticos y las estrategias de gestión integradas.
- La vigilancia y la investigación continuas son cruciales para combatir esta infección.
Videos de Conceptos Relacionados
01:28Fungal Phylum Microsporidia
111
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
111
01:26Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K
01:25Factors Influencing Drug Absorption: Disease States and Pharmacology
766
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
766
01:26Anticholinesterase Agents: Poisoning and Treatment
1.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.0K
01:17Drugs for Treatment of Diarrhea-Predominant IBS
292
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
292
01:24Principles of Drug Action
6.6K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.6K